Body MRI research at Stanford is fostered by a tight link between research scientists in the Department of Radiology, the University, and throughout the Bay Area. Clinical scanners have platforms identical to dedicated research scanners, enabling rapid clinical translation. These efforts are supported by multiple NIH grants.
MRI can be a powerful resource in clinical trials, not only to determine the efficacy of pharmaceuticals, devices, and behavioral interventions, but also in optimizing recruitment and assessing safety. Because MRI involves no ionizing radiation, it subjects participants to minimal risk. With its tremendous flexibility, an optimal imaging strategy can be designed for your specific aims. To get help or additional information contact us.
| Shreyas Vasanawala, MD/ PhD |
Our research interests are Novel MRI Hardware, Fast MRI Techniques & Quantitative MRI Methods Many applications of body MRI may be improved or enabled by optimization of dedicated radiofrequency receiver arrays. Thus, we are actively developing new approaches to design and construction of miniaturized radiofrequency receiver arrays for optimized and personalized MRI exams. To enable more children to undergo MRI and to enable higher resolution imaging in adults, we are developing and validating methods that combine advanced parallel imaging, compressed sensing, deep learning approaches to image reconstruction and analysis, motion correction, and higher dimensional data acquisition strategies. Development and validation of accurate and precise cardiovascular flow and function measurements, noninvasive renal function assessment, and tumor therapy response. |
| Bruce Daniel, MD |
Dr. Daniel's research interests are Breast MRI & Interventional MRI. |
| Pejman Ghanouni, MD/PhD |
Dr. Ghanouni's research interests include MR guided HIFU palliation of painful metastases to bone and MR guided HIFU treatment of soft tissue tumors of the extremities. MR guided HIFU palliation of painful metastases to bone: Bones are the third most common site of metastasis, and pain from these metastases is the most common cause of cancer-related pain. External beam radiotherapy (EBRT) is the standard of care, with > 40% of patients experiencing at least a 50% reduction in pain at 1 month. However, approximately one-third of patients do not have pain relief after radiation, and retreatment with EBRT is limited by toxicity to normal tissue. MRgHIFU has recently completed a phase 3 trial assessing the effectiveness and safety of this method for palliation of pain in patients with bone metastases.
Figure 6: Images from the pre-treatment PET-CT and MR demonstrate a metabolically active, enhancing expansile mass in the right ischial tuberosity. The patient was unable to sit on his right buttock because of 8 out of 10 pain from this lesion. The MR-HIFU images demonstrate thermal dose, in blue, deposited on the posterior aspect of the right ischial tuberosity. Post-treatment PET-CT and MR images demonstrate diminished metabolic activity and enhancement in a distribution that matches the region of the thermal deposition from the HIFU treatment. More importantly, this patient was able to sit normally within one week, with a pain score of between 0 - 1 out of 10 at 12 weeks. MR guided HIFU treatment of soft tissue tumors of the extremities: Soft tissue tumors of the extremity occur in people of all ages. The standard of care is complete surgical resection of the tumor, and, in the case of malignant tumors, an additional margin of healthy tissue. Despite advances in surgical techniques, imaging technologies, chemotherapy regimens and radiotherapy, the morbidity associated with treating these tumors and the survival of patients with malignant tumors has not significantly improved in the past 20 years. We are adapting MRgHIFU techniques to the treatment of benign and malignant soft tissue tumors of the extremities, culminating in a Phase 1 clinical trial.
Figure 7: A photo of the right thigh of a patient with recurrent desmoid tumors, requiring three surgeries and multiple treatments with radiation, which are current standards of care. Despite the treatment, the patient is disfigured, had a pathologic fracture of the femur, and poor wound healing. Patients such as this would benefit greatly from a non-invasive therapy such as MRgHIFU. Images in the top right represent T1 weighted MR images of a human cadaveric lower leg undergoing HIFU planning. The yellow cylinders represent planned areas of sonication, and the blue areas are the treated areas with thermal dose deposited. The bottom right photo is of the tissue specimen showing the coagulated treatment area. |
| Andreas Loening, MD/PhD |
Dr Loening’s research interests include improving imaging quality and diagnostic capabilities of MRI in genitourinary disease via the application of advanced pulse sequences and new imaging protocols. Variable Refocusing Flip Angle Single Shot Fast Spin Echo Imaging The most time consuming portion of most pelvic imaging protocols is the acquisition of T2-weighted imaging utilizing 2D fast-spin echo (FSE) sequences; this often requires 20-30 minutes of scanner time. Additionally, these 2D fast-spin echo sequences are often compromised by artifacts arising from respiratory motion and bowel peristalsis. Due to their greatly increased speed single shot fast spin echo (SSFSE) sequences have been proposed as a replacement for FSE as they essentially eliminate artifacts from motion, albeit at a cost of reduced signal-to-noise (SNR) and image blurring arising from T2-decay occurring during signal acquisition. We have incorporated variable refocusing flip angles into SSFSE (vrfSSFSE) in order to improve its image quality compared to conventional SSFSE as well as to further decrease imaging time via reductions in radiofrequency energy deposition (SAR constraints). High-Resolution Post-Contrast Imaging for Tumor Staging in the Pelvis: As another approach to move away from the use of time-consuming and artifact-prone 2D fast-spin echo sequences in the pelvis, we have been exploring the relative diagnostic capability of a single high-resolution 3D post-contrast T1-weighted acquisition versus conventional multi-planar 2D FSE based imaging protocols. This high-resolution T1-weighted sequence allows reformation of arbitrary imaging planes retrospectively, removing the need for the acquisition of multiple separate planes of imaging as well as eliminating errors in acquisition plane prescription. |
| Stephanie Chang, MD | |
| Ryan Brunsing, MD/PhD | |
| Vipul Sheth, MD/PhD | |
| Ali Syed, MD | |
| Rachelle Bitton, PhD | |
| Negaur Iranpour, MD |
